跳至主要内容
临床试验/NCT00622219
NCT00622219已完成不适用

Mentored Clinical Career Award in Adolescent Substance Abuse

Boston Children's Hospital2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
96
试验地点
2
主要终点
Percentage days abstinent from any substance use during the past 90 days, as measured by self-report via a Time Line Follow Back calendar (TLFB).

研究概览

简要总结

The goal of this project is to determine the barriers to, and risks and benefits of random laboratory drug testing for adolescents with identified drug or alcohol problems.

详细描述

Use of drugs and alcohol is associated with a variety of health care problems, making settings where adolescents receive routine medical care ideal for implementation of routine screening and early intervention. However, little research has been conducted on the efficacy of interventions for adolescent primary care patients who are using drugs or alcohol. Urine drug testing can be used for a variety of indications, including school or work based population surveillance, verification of history, or monitoring of individuals who are in treatment for a drug-use disorder. This study will focus exclusively on the therapeutic use of urine drug testing. Drug testing can be a useful therapeutic adjuvant for patients with drug-use disorders in a variety of settings.

This study will investigate the use of random laboratory drug testing as a therapeutic intervention for teens with drug problem use, abuse or dependence. We have 5 objectives:

  1. To develop a standardized protocol for random urine drug testing, produce a manual and training protocol, and refine the protocol in preparation for a future efficacy trial.
  2. To estimate the cost of a random drug-testing program.
  3. To determine the factors that are associated with willingness to be tested, and barriers to enrolling adolescents in laboratory drug testing programs.
  4. To perform an initial, small-scale experimental trial of the random drug testing protocol. The purpose of this trial is to estimate the effect size of the intervention and will be used in calculating the sample size for a future stage 1b trial.
  5. To determine the potential risks to adolescents who participate in a random drug testing program, including possible breach of confidentiality, greater conflict between the parent and child, more difficulty with communication between clinician and patient, increased use of drugs not detected by routine urine screens (i.e. inhalants), and increased use of strategies and products known to defeat drug tests.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
12 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Adolescents ages 12-21
  • Participants must have use of alcohol, cannabis, or another substance on at least 2 occasions in the 30 days preceding their initial assessment or 6 or more times in the past 90 days
  • Participants must have health insurance or be willing to pay for the laboratory costs associated with drug testing.
  • Participants must provide informed assent and, for those under 18, parental consent.

排除标准

  • Participants who require immediate hospitalization or immediate referral to residential substance abuse treatment
  • Participants who cannot understand or read English at a 6th grade reading level
  • Participants who are enrolled in the ASAP buprenorphine program
  • Participants who report previous use of inhalants or any other substance that is not easily detected with urine drug testing

结局指标

主要结局

Percentage days abstinent from any substance use during the past 90 days, as measured by self-report via a Time Line Follow Back calendar (TLFB).

时间窗: 90 days

次要结局

  • Adolescent willingness to participate a in drug testing program.(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sharon Levy

Assistant Professor of Pediatrics

Boston Children's Hospital

研究点 (2)

Loading locations...

相似试验